| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +50K | 100% | $1.01 | +$50.3K |
| Sells | 0 | ||||
| Net | +2 | +50K | 100% | +$50.3K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Michael Tardugno | Executive Chairman of Board, Director | $364K | +$25.8K | +7.61% | Dec 18, 2024 |
| Stacy Lindborg | President and CEO, Director | $259K | +$24.5K | +10.5% | Sep 10, 2024 |
| Sebastien Hazard | Chief Medical Officer | $19.6K | Dec 7, 2023 | ||
| Robert W. Hooper | Director | Jun 13, 2022 | |||
| Timothy J. Tumminello | Controller | Jun 13, 2022 | |||
| Constantine J. Kardaras | Chief Accounting Officer | Jun 13, 2022 | |||
| Corinne Le Goff | President and CEO, Director | Mar 17, 2023 | |||
| David Gaiero | Chief Financial Officer | Jun 1, 2024 | |||
| Frederick J. Fritz | Director | Sep 10, 2024 | |||
| Christine A. Pellizzari | Director | Sep 10, 2024 | |||
| Donald P. Braun | Director | Sep 10, 2024 | |||
| James E. Dentzer | Director | Sep 10, 2024 | |||
| Jeffrey Wayne Church | Cfo | Mar 15, 2024 | |||
| Susan Eylward | General Counsel and Corp Sec | Oct 7, 2024 | |||
| Pok Yu Augustine Chow | Director | Mar 17, 2023 | |||
| Khursheed Anwer | Chief Scientific Officer | Sep 10, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|